{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "KRW", "exchange": "KOE", "shortName": "Alteogen", "longName": "ALTEOGEN Inc.", "market": "kr_market", "marketState": "PREPRE", "earningsTimestamp": 1679309940, "earningsTimestampStart": 1684148340, "earningsTimestampEnd": 1684497600, "epsCurrentYear": -84.0, "priceEpsCurrentYear": -525.0, "sharesOutstanding": 13577300, "fiftyDayAverage": 42357.0, "fiftyDayAverageChange": 1743.0, "fiftyDayAverageChangePercent": 0.041150223, "twoHundredDayAverage": 42026.707, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Asia/Seoul", "exchangeTimezoneShortName": "KST", "gmtOffSetMilliseconds": 32400000, "esgPopulated": false, "regularMarketChangePercent": -0.45146728, "regularMarketPrice": 44100.0, "regularMarketChange": -200.0, "regularMarketTime": 1683873015, "regularMarketDayHigh": 44850.0, "regularMarketDayRange": "43350.0 - 44850.0", "regularMarketDayLow": 43350.0, "regularMarketVolume": 279187, "regularMarketPreviousClose": 44300.0, "bid": 44150.0, "ask": 44200.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "KOSDAQ", "financialCurrency": "KRW", "regularMarketOpen": 44250.0, "averageDailyVolume3Month": 720082, "averageDailyVolume10Day": 474086, "fiftyTwoWeekLowChange": 16225.0, "fiftyTwoWeekLowChangePercent": 0.5820628, "fiftyTwoWeekRange": "27875.0 - 65000.0", "fiftyTwoWeekHighChange": -20900.0, "fiftyTwoWeekHighChangePercent": -0.32153845, "fiftyTwoWeekLow": 27875.0, "fiftyTwoWeekHigh": 65000.0, "twoHundredDayAverageChange": 2073.293, "twoHundredDayAverageChangePercent": 0.04933275, "marketCap": 598758916096, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "averageAnalystRating": "1.3 - Strong Buy", "firstTradeDateMilliseconds": 1418342400000, "priceHint": 2, "symbol": "196170.KQ"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "62, Yuseong-daero", "address2": "1628beon-gil Yuseong-gu", "city": "Daejeon", "zip": "34054", "country": "South Korea", "phone": "82 4 2384 8780", "fax": "82 4 2384 8770", "website": "https://www.alteogen.com", "industry": "", "sector": "", "longBusinessSummary": "ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth hormone that is in the Phase IIa clinical trial; and ALT-Q2, a long-acting active form of coagulation factor VII for the treatment of hemophilia based on its NexP technology. It is also involved in the development of ALT-P7, a targeted breast/gastric cancer drug that is in the Phase I clinical trial; and ALT-Q5, an antibody-drug conjugate (ADC) for the treatment of ovarian cancer based on its NexMab ADC technology. The company has a strategic alliance with Kissei Pharmaceutical to develop Aflibercept that has completed pre-clinical trial; and Cristalia for the development of Trastuzumab, which is in the Phase II clinical trial for the treatment of breast cancer. ALTEOGEN Inc. was founded in 2008 and is headquartered in Daejeon, South Korea.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Soon-Jae  Park Ph.D.", "title": "Chief Exec. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hang Yeon  Kim", "title": "CFO & Exec. VP", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Seung Joo  Lee", "age": 59, "title": "CTO, Exec. VP and Head of R&D Center", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Hye-Shin  Chung Ph.D.", "title": "Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Sang-Mee  Lee", "title": "VP & Head of Research Planning", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Sang Woo  Kang", "title": "Sr. VP of Management Support Group", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Tae-Yon  Chun J.D., Ph.D.", "title": "Sr. VP & Corp. Alliance Officer (CAO)", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kyuwan  Kim", "title": "Sr. VP & Head of New Drug Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Vivek  B Shenoy M.B.A., Ph.D.", "title": "Chief Bus. Devel. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 9, "shareHolderRightsRisk": 5, "overallRisk": 10, "governanceEpochDate": 1682899200, "maxAge": 86400}}], "error": null}}